Finance Watch: Lilly’s Gateway Labs, Deerfield’s Cure Offer Biotechs Space To Grow

Brandon Capital Closed A $180m Fund

Private Company Edition: Scrip spoke with the leaders of Gateway Labs and Cure at the BIO International Convention about their mini ecosystems. Also, radiopharmaceutical firm ITM raised €188m ($201.9m), Santa Ana Bio emerged with $168m and Alzheon’s series E totaled $100m.

Finance Watch Private Company
• Source: Shutterstock

The road to starting up and funding a new biopharmaceutical venture is paved with plenty of speedbumps, but certain big pharma companies and investors have made efforts to smooth the path for start-ups that they view as having a good chance of growing into substantial contributors to the industry. Eli Lilly and Company recently opened its first Gateway Labs location outside of San Francisco and the Deerfield Management-backed health care innovation campus known as Cure in New York City is filling up.

[Sidebar#SC150424]

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from BIO

More from Conferences